JESSICA TRAN: Open Payments
NPI 1245697994 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,909 in 89 payments from 21 companies in 2025. Trend: 2023 $2,091 · 2024 $2,314 · 2025 $4,909
Food & beverage: $2,141Speaker / faculty: $1,930Travel & lodging: $839
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 19 | $3,287 |
| Fresenius USA Marketing, Inc. | 14 | $324 |
| Novartis Pharmaceuticals Corporation | 7 | $274 |
| Vifor Pharma, Inc. | 7 | $149 |
| Amgen Inc. | 5 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $90 |
| Mallinckrodt Hospital Products Inc. | 5 | $89 |
| Alexion Pharmaceuticals, Inc. | 4 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79 |
| NxStage Medical, Inc. | 1 | $76 |
Products named: Vafseo, VELPHORO, Fabhalta, Veltassa, JARDIANCE, Kerendia, ULTOMIRIS, NXSTAGE SYSTEM ONE.
Industry payments across LA — which companies pay providers there.
